Quebec Pancreas Cancer Study

Launched by GEORGE ZOGOPOULOS · Sep 25, 2019

Keywords

ClinConnect Summary

The Quebec Pancreas Cancer Study is a research project aimed at better understanding pancreatic cancer and related conditions. The study is looking for people who have been diagnosed with pancreatic cancer, certain types of related cancers (like bile duct or gallbladder cancer), or pre-cancerous conditions. It also seeks to include individuals who have a strong family history of pancreatic cancer or specific hereditary cancer syndromes. This means if you have three or more family members with pancreatic cancer or two family members diagnosed at a young age, you may qualify to participate.

If you join this study, you will provide information about your health and family history, as well as some biological samples, like blood or tissue. The goal is to gather valuable data that can help researchers learn more about pancreatic cancer and improve future treatments. The study is currently looking for participants aged 65 to 74, and anyone can join regardless of gender. If you think you might be eligible or are interested in learning more, it’s a great opportunity to contribute to important cancer research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individual diagnosed with pancreatic cancer.
• • Individual diagnosed with a related cancer (bile duct cancer, ampullary cancer, duodenal cancer, gallbladder cancer).
• • Individual diagnosed with pancreatic neoplasm or pancreatic cyst.
• • High-risk individuals with Familial Pancreatic Cancer (3 or more relatives affected with adenocarcinoma).
• • High-risk individuals with 2 first-degree relatives affected with young-onset pancreatic adenocarcinoma (≤ 50 years old).
• • High-risk individuals with one of the following Hereditary Cancer Syndromes: Peutz-Jeghers Syndrome (STK11 gene mutation), Familial Atypical Multiple Mole Melanoma Syndrome (CDKN2A gene mutation), or Hereditary Pancreatitis (PRSS1 gene mutation) with clinical manifestations.
• • High-risk individuals with one of the following Hereditary Cancer Syndromes: Hereditary Breast and Ovarian Cancer Syndrome (BRCA1, BRCA2 or PALB2 gene mutation), Lynch Syndrome (MLH1, MSH2, MSH6, PMS2 or EPCAM gene mutation), or Hereditary Breast Cancer (ATM gene mutation), WITH a family history of cancer.
• Exclusion Criteria:
• • High-risk individuals with one of the following Hereditary Cancer Syndromes: Hereditary Breast and Ovarian Cancer Syndrome (BRCA1, BRCA2 or PALB2 gene mutation), Lynch Syndrome (MLH1, MSH2, MSH6, PMS2 or EPCAM gene mutation), or Hereditary Breast Cancer (ATM gene mutation), WITHOUT a family history of cancer.